[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fv-0kBigfcLaMw20hnBOoeNBTv98ptHuE3LI_NrGlXC8":3,"$f9Vw6N9UOTmmDgp44yughH_KHle4rKMfmuP5rsDrnvQw":13,"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":17,"$ffXx-kwRPr6iOgiyM2gCZAM1otEd-cYJnhqadezBJdcI":21},{"code":4,"msg":5,"message":6,"data":7,"success":12},200,"操作成功",null,{"pageNo":8,"pageSize":9,"result":10,"totalSize":11},1,10,[],0,true,{"code":4,"msg":5,"message":6,"data":14,"success":12},{"authors":15,"appraiseDimensionScoresVos":16},[],[],{"code":18,"msg":19,"message":6,"data":6,"success":20},401,"认证失败，无法访问系统资源",false,{"code":4,"msg":5,"message":6,"data":22,"success":12},{"id":23,"specialistId":24,"specialistAssistants":25,"profilePhoto":26,"specialistName":27,"hospital":28,"department":29,"postsTitle":30,"materialTotal":31,"videoTotal":11,"isConcern":20,"title":32,"coverVertical":33,"coverAcross":34,"content":35,"description":36,"views":37,"likes":11,"isThumbsUp":20,"isCollection":20,"collections":11,"createTime":38,"seoTitle":32,"seoKeywords":39,"seoDescription":40,"shelvesTime":41,"version":42,"menus":43,"menuId":45,"type":8,"quality":62,"commentCount":11,"isComment":8},86416,1073546,[],"https://ystcdn.venuertc.com/venue/app/51989/2026-09-24/a17541e1-1ba3-4890-bd02-688d3e73fa73.png","王雪","天津东丽驯海医院","药剂科","初级药师",3,"糖尿病患者必备：如何根据自身情况合理选择降糖药？——药剂科超实用全流程指南","","https://ystcdn.venuertc.com/venue/AI/6172b1f7-4649-46ec-9ea6-654b4ad69a60.jpg","\u003Cdiv class=\"sci_glucose_wrap\">\n  \u003Ch1 id=\"material_title\" class=\"sci_glucose_title\">糖尿病患者必备：如何根据自身情况合理选择降糖药？——药剂科超实用全流程指南\u003C/h1>\n\n  \u003Cdiv class=\"sci_glucose_section sci_bg_one\">\n    \u003Ch2>一、评估基础情况，选药从个体差异出发 🌱\u003C/h2>\n    \u003Cdiv>\n      \u003Cstrong>1. 血糖特征：\u003C/strong>\u003Cbr />\n      针对不同的血糖表现，降糖药物的选择重点也不同：\u003Cbr />\n      \u003Cul>\n        \u003Cli>仅餐后血糖升高：建议优先选用专门作用于餐后血糖的药物，如\u003Cspan>α糖苷酶抑制剂、格列奈类、DPP‑4抑制剂\u003C/span>，帮助饭后血糖控制更理想。\u003C/li>\n        \u003Cli>空腹和餐后血糖都高、基础血糖显著升高：更适合\u003Cspan>二甲双胍、SGLT‑2i、GLP‑1RA、长效磺脲/基础胰岛素\u003C/span>，起到全天候的血糖管理效果。\u003C/li>\n        \u003Cli>血糖波动大、脆性糖尿病：低血糖风险低的药物更安全，要特别注意慎用磺脲、格列奈。\u003C/li>\n      \u003C/ul>\n\n      \u003Cstrong>2.糖化血红蛋白（HbA1c）基线:\u003C/strong>\u003Cbr />\n      \u003Cul>\n        \u003Cli>HbA1c＜7.5%：可考虑单药治疗，从最基础的控制开始。\u003C/li>\n        \u003Cli>HbA1c≥7.5%：建议直接联合两种药物，早期强化管理，防止病情进展。\u003C/li>\n        \u003Cli>HbA1c≥10%并且伴有明显高血糖症状：首选胰岛素，控制更快更安全。\u003C/li>\n      \u003C/ul>\n\n      \u003Cstrong>3. 体重：\u003C/strong>\u003Cbr />\n      \u003Cul>\n        \u003Cli>体重超重/肥胖（BMI≥24）：首选GLP‑1受体激动剂和SGLT‑2抑制剂，有减重效果；二甲双胍也能轻度减重，还要尽量避免磺脲、胰岛素这类容易让人增重的药物。\u003C/li>\n        \u003Cli>偏瘦/体重低：此时可以选择对于体重有适度提升作用的磺脲、胰岛素，避免用减重型药物。\u003C/li>\n      \u003C/ul>\n\n      \u003Cstrong>4. 年龄：\u003C/strong>\u003Cbr />\n      \u003Cul>\n        \u003Cli>老年人（≥65岁，尤其中体弱、独居）：防低血糖排第一，优先选SGLT‑2i、DPP‑4i、二甲双胍（肾功能允许时），减少长效磺脲应用。血糖目标可适当放松。\u003C/li>\n        \u003Cli>中青年：为了减少远期并发症，可以追求更严格的血糖控制，兼顾心血管和减重获益。\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"sci_glucose_section sci_bg_two\">\n    \u003Ch2>二、合并症和器官保护：降糖药不止“降糖”这件事💖\u003C/h2>\n    \u003Cdiv>\n      当合并心脏、肾脏、心衰等问题时，降糖药物的选择更强调“器官保护”，而非单纯的血糖下降幅度：\n      \u003Cul>\n        \u003Cli>\u003Cb>动脉粥样硬化性心血管病ASCVD：\u003C/b>GLP‑1RA首选，因其明确心血管获益，SGLT‑2i也适合。\u003C/li>\n        \u003Cli>\u003Cb>心力衰竭：\u003C/b>首要SGLT‑2抑制剂，已被证实能降低心衰住院风险。\u003C/li>\n        \u003Cli>\u003Cb>糖尿病肾病：\u003C/b>SGLT‑2i优先。它对肾脏保护突出，GLP‑1RA有部分辅助价值。注意二甲双胍、磺脲要按肾功能调整用量。\u003C/li>\n        \u003Cli>\u003Cb>脂肪肝：\u003C/b>GLP‑1RA、SGLT‑2i、二甲双胍效果较佳。\u003C/li>\n        \u003Cli>\u003Cb>反复低血糖史：\u003C/b>首选低血糖发生率低的二甲双胍、SGLT‑2i、DPP‑4i、GLP‑1RA。避免磺脲、格列奈。\u003C/li>\n        \u003Cli>\u003Cb>消化道疾病：\u003C/b>二甲双胍、GLP‑1RA较容易引起胃肠道不适，尽量从小剂量开始或考虑替换。\u003C/li>\n        \u003Cli>\u003Cb>骨质疏松、骨折高风险：\u003C/b>避免噻唑烷二酮类，因为有增加骨折的风险。\u003C/li>\n        \u003Cli>\u003Cb>泌尿生殖系统高感染风险：\u003C/b>SGLT‑2i可增加泌尿道感染风险，如既往就易感染则需谨慎使用。\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"sci_glucose_section sci_bg_three\">\n    \u003Ch2>三、常见降糖药物“适配场景”速查清单🔍\u003C/h2>\n    \u003Cdiv>\n      \u003Cul>\n        \u003Cli>\u003Cstrong>二甲双胍：\u003C/strong>2型糖尿病治疗基础首选，能轻度减重、低血糖风险极低（需排除严重肾衰竭、缺氧性疾病），但常见胃肠反应。\u003C/li>\n        \u003Cli>\u003Cstrong>SGLT‑2抑制剂（列净类）：\u003C/strong>具备心肾保护、减重、降压等多重作用，需当心泌尿感染、酮症酸中毒、下肢截肢等（部分品种）、脱水。\u003C/li>\n        \u003Cli>\u003Cstrong>GLP‑1受体激动剂（肽类）：\u003C/strong>强效减重兼具心血管保护，每日/每周注射制剂为主，易有胃肠道不适。\u003C/li>\n        \u003Cli>\u003Cstrong>DPP‑4抑制剂（列汀类）：\u003C/strong>低血糖极少，适合耐受性低人群且对体重影响中性，口服方便。\u003C/li>\n        \u003Cli>\u003Cstrong>磺脲类（格列X）：\u003C/strong>降糖效果强、价格低廉，但低血糖风险大和易增重，老年用药需特别警惕。\u003C/li>\n        \u003Cli>\u003Cstrong>格列奈类：\u003C/strong>主要降低餐后血糖，起效快，适合用餐不规律者，但需警惕低血糖和增重。\u003C/li>\n        \u003Cli>\u003Cstrong>α糖苷酶抑制剂（阿卡波糖等）：\u003C/strong>突出降低餐后血糖，常见腹胀、排气等副作用，主食摄入多者更适用。\u003C/li>\n        \u003Cli>\u003Cstrong>TZDs（噻唑烷二酮）：\u003C/strong>改善胰岛素抵抗，容易引起增重、水肿、心衰及骨折。\u003C/li>\n        \u003Cli>\u003Cstrong>胰岛素：\u003C/strong>各种类型糖尿病、孕期糖尿病首选，降糖“能力”最强但增重与低血糖风险也较高。\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"sci_glucose_section sci_bg_four\">\n    \u003Ch2>四、个体化因素全面考虑💡\u003C/h2>\n    \u003Cdiv>\n      由于降糖药物种类多元，药剂科建议不仅考虑血糖、并发症，还要兼顾实际生活和经济环境：\u003Cbr />\n      \u003Cul>\n        \u003Cli>依从性：如果不喜欢注射类药物，可优先选择口服药；如果经常忘记服药，可选择每周一次GLP‑1RA制剂或每日一次口服药。\u003C/li>\n        \u003Cli>经济条件：二甲双胍、磺脲、阿卡波糖较为经济实惠；GLP‑1RA、SGLT‑2i价格相对较高，选药时可做权衡。\u003C/li>\n        \u003Cli>妊娠/备孕：孕期及哺乳期严格禁用口服降糖药，须首选胰岛素方案。\u003C/li>\n      \u003C/ul>\n      这些细节决定患者长期效果和用药舒适度，选择更科学合理。\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"sci_glucose_section sci_bg_five\">\n    \u003Ch2>五、“一图”速览合理选药流程🗂️\u003C/h2>\n    \u003Cdiv>\n      \u003Col>\n        \u003Cli>确诊2型糖尿病—立刻结合生活方式干预及二甲双胍启动（前提无绝对禁忌）。\u003C/li>\n        \u003Cli>评估：心血管疾病、心衰、肾病并存情况，结合体重、年龄、肾功能综合判定。\u003C/li>\n        \u003Cli>如有心脏/肾脏高危，直接加用SGLT‑2i或GLP‑1RA（不强制依赖糖化血红蛋白指标，器官保护为主）。\u003C/li>\n        \u003Cli>若血糖仍未达标，再逐步叠加其它降糖药，且低血糖高风险群体避开磺脲。\u003C/li>\n        \u003Cli>1型糖尿病和妊娠糖尿病患者：胰岛素为主线。\u003C/li>\n      \u003C/ol>\n      这个流程助您一步一步，选药更科学！\n    \u003C/div>\n  \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n.sci_glucose_wrap {\n  max-width: 800px;\n  margin: 30px auto;\n  box-shadow: 0 2px 8px rgba(80,150,110,.09);\n  background: #fff;\n  font-family: \"Segoe UI\", \"Microsoft Yahei\", Arial, sans-serif;\n  border-radius: 14px;\n  padding: 24px 24px 24px 24px;\n}\n.sci_glucose_title {\n  margin: 0;\n  padding: 20px 0 18px 0;\n  font-size: 2.1em;\n  text-align: center;\n  font-weight: bold;\n  color: #2c543c;\n  border-bottom: 2px solid #e6e6e6;\n  letter-spacing: 2px;\n}\n.sci_glucose_section {\n  margin-top: 35px;\n  border-radius: 10px;\n  padding: 24px 18px 18px 28px;\n  font-size: 1.13em;\n  line-height: 2.08;\n  box-sizing: border-box;\n}\n.sci_bg_one {\n  background: linear-gradient(95deg, #eafbe2 0%, #fcfcfc 100%);\n}\n.sci_bg_two {\n  background: linear-gradient(95deg, #e2f4fa 0%, #fefefe 100%);\n}\n.sci_bg_three {\n  background: linear-gradient(95deg, #f8e9ff 0%, #fdfcff 100%);\n}\n.sci_bg_four {\n  background: linear-gradient(95deg, #fffce1 0%, #f6fff9 100%);\n}\n.sci_bg_five {\n  background: linear-gradient(95deg, #dcdcff 0%, #fafafe 100%);\n}\n.sci_glucose_section ul, .sci_glucose_section ol {\n  padding-left: 1.2em;\n  margin-top: 10px;\n  margin-bottom: 10px;\n}\n.sci_glucose_section li {\n  margin-bottom: 8px;\n}\n.sci_glucose_section strong {\n  color: #21564d;\n}\n.sci_glucose_section span {\n  background: #f2fff5;\n  border-radius: 5px;\n  padding: 0 6px;\n}\n.sci_glucose_section b {\n  color: #4b3496;\n}\n.sci_glucose_section em {\n  color: #ce472b;\n  font-style: normal;\n  font-weight: bold;\n}\n.sci_glucose_section h2 {\n  font-size: 1.32em;\n  font-weight: bold;\n  color: #21564d;\n  margin-top: 0;\n  margin-bottom: 10px;\n  background: rgba(76,175,80,.06);\n  padding: 10px 18px;\n  border-radius: 6px;\n  letter-spacing: 1px;\n  box-shadow: none;\n  border:none;\n}\n@media (max-width: 600px) {\n  .sci_glucose_wrap {padding:12px;}\n  .sci_glucose_section {padding:18px 7px 12px 13px;}\n  .sci_glucose_title {font-size:1.1em;padding:12px 0 8px 0;}\n}\n\u003C/style>","\u003Cdiv class=\"sci_glucose_wrap\">\n  \u003Ch1 id=\"material_title\" class=\"sci_glucose_title\">糖尿病患者必备：如何根据自身情况合",1244,"2026-09-30 10:22:22","糖尿病, 降糖药, 血糖控制, 二甲双胍, SGLT-2抑制剂, 糖化血红蛋白, 体重管理, 年龄因素","本文为糖尿病患者提供科学合理的降糖药选择指南，结合血糖特征、合并症等因素，帮助您更有效地控制血糖，改善健康生活。","2026-10-01 09:58:00",2,[44],{"menuId":45,"menuName":46,"parentId":11,"orderNum":42,"path":47,"component":48,"isFrame":49,"isCache":50,"menuType":51,"visible":8,"status":11,"createDept":6,"remark":33,"createTime":52,"children":53,"columnImage":54,"columnLogo":55,"uncheckedLogo":6,"checkedLogo":6,"isHot":8,"isHome":11,"forceLogin":11,"color":56,"seoTitle":57,"seoKeywords":58,"seoDescription":59,"contentNum":6,"promotionalPoster":60,"menuFrame":20,"innerLink":20,"parentView":20,"routeName":61,"routerPath":47,"componentInfo":48},"1986713082609147906","健康科普","article","/article.html","1","0","T","2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","慢性病"]